What causes hyperbilirubinemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hyperbilirubinemia

Hyperbilirubinemia is caused by an imbalance between bilirubin production and elimination, with three major categories of causes: prehepatic (excessive bilirubin production), intrahepatic (impaired bilirubin processing), and posthepatic (biliary obstruction). 1

Classification by Bilirubin Type

Unconjugated (Indirect) Hyperbilirubinemia

Prehepatic Causes

  • Hemolytic disorders:

    • Hemolytic anemias (sickle cell disease, thalassemia, hereditary spherocytosis)
    • Glucose-6-phosphate dehydrogenase deficiency
    • Absorption of large hematomas
    • Increased red blood cell destruction 1, 2
  • Laboratory findings:

    • Elevated reticulocyte count
    • Decreased hemoglobin
    • Abnormal red cell morphology
    • Increased end-tidal carbon monoxide (ETCOc) 3

Intrahepatic Causes

  • Enzyme deficiencies:

    • Gilbert syndrome (reduced glucuronosyltransferase activity) - affects 5% of the population 1
    • Crigler-Najjar syndrome
  • Drug-induced:

    • Certain antiviral medications can impair bilirubin conjugation 4

Conjugated (Direct) Hyperbilirubinemia

Intrahepatic Causes

  • Hepatocellular injury:

    • Viral hepatitis (A, B, C, D, E, Epstein-Barr virus)
    • Alcoholic liver disease
    • Autoimmune hepatitis
    • Drug-induced liver injury (acetaminophen, penicillin, oral contraceptives, anabolic steroids, chlorpromazine) 1
    • Sepsis or low perfusion states 1
  • Cholestatic disorders:

    • Primary biliary cholangitis
    • Primary sclerosing cholangitis
    • Medication-induced cholestasis 1

Posthepatic (Obstructive) Causes

  • Intrinsic biliary obstruction:

    • Choledocholithiasis (gallstones in bile duct)
    • Cholangitis
    • Cholangiocarcinoma
    • Gallbladder cancer 1
  • Extrinsic biliary compression:

    • Pancreatic tumors
    • Pancreatitis causing biliary obstruction
    • Lymphoma
    • Other malignancies compressing bile ducts 1, 5

Epidemiology of Causes

In the United States, the most common causes of jaundice fall into four categories:

  1. Hepatitis
  2. Alcoholic liver disease
  3. Blockage of common bile duct by gallstone or tumor
  4. Toxic reaction to drugs or medicinal herbs 1

In severe jaundice cases, European studies have found malignancy to be the most common cause, followed by sepsis/shock (22%), cirrhosis (21%), common bile duct stones (13%), drugs (0.5%), autoimmune hepatitis (0.2%), and viral hepatitis (0.2%) 1.

Special Populations

Neonates

  • 60% of term and 80% of preterm infants develop jaundice in the first week of life 6
  • Primarily due to immature liver conjugation systems
  • Hemolytic disorders are a common cause of extreme neonatal hyperbilirubinemia 2

Post-procedural

  • Severe hyperbilirubinemia after transjugular intrahepatic portosystemic shunts (TIPS) creation indicates poor prognosis
  • Risk factors include non-alcoholic liver disease and prolonged prothrombin time 7

Diagnostic Approach

  1. Fractionation of bilirubin to determine if elevation is predominantly conjugated or unconjugated 3

    • Direct (conjugated) bilirubin >20-30% of total or >1.0 mg/dL when total bilirubin is ≤5 mg/dL indicates conjugated hyperbilirubinemia
  2. Liver function tests:

    • ALT, AST, alkaline phosphatase, GGT, albumin, PT/INR 3
  3. Hemolysis evaluation:

    • Complete blood count with differential
    • Blood smear for red cell morphology
    • Reticulocyte count 3
  4. Imaging:

    • Abdominal ultrasound is first-line for suspected biliary obstruction (sensitivity 32-100%, specificity 71-97%) 1, 3
    • MRI with MRCP for better biliary anatomy evaluation when obstruction is suspected 3

Common Pitfalls to Avoid

  • Delayed evaluation of conjugated hyperbilirubinemia, which always represents pathology requiring prompt investigation 3
  • Overdiagnosis and unnecessary testing for mild indirect hyperbilirubinemia 3
  • Confusing direct bilirubin with conjugated bilirubin in laboratory reports 3
  • Attributing mild indirect hyperbilirubinemia to significant liver disease when it may represent a benign variant like Gilbert's syndrome 3
  • Failing to consider drug-induced causes, especially in patients on antiviral medications 4

Understanding the pattern of bilirubin elevation (conjugated vs. unconjugated) is the key first step in determining the underlying cause of hyperbilirubinemia and directing appropriate further evaluation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neonatal Hyperbilirubinemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperbilirubinemia in the setting of antiviral therapy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.